UK pharmacy owner warns of severe drug shortages affecting statins, heart medication, and other essential medicines
By
Robert Rowlands
Summary
Pharmacy owner Mo Almobaraki warns that the UK is experiencing its most severe drug shortage on record, affecting millions who take statins, HRT, Creon, beta blockers, and blood pressure/heart medication. The shortages have caused prices of everyday medicines to skyrocket, raising concerns about patient access to essential treatments.
Source
bskyUK pharmacy owner warns of severe drug shortages affecting statins, heart medication, and other essential medicinesmirror.co.ukKey quotes
· 3 pulledIt has become increasingly difficult to obtain very basic medicine
The most severe drug shortage on record has caused the price of everyday medicines to rocket
People are worried
You might also wanna read
Study Finds 20% of Cancer Drugs in 4 African Nations Defective
A research study reveals that nearly 20% of cancer drugs in four African nations are defective, lacking essential ingredients for treating t
dw.com·1y ago
Conflicts of interest threaten integrity of GLP-1 therapy guidance, experts warn
This article discusses the risks of conflicts of interest in clinical guidance for GLP-1 receptor agonists (like Ozempic, Wegovy) used for o
bit.ly·7d ago
Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption
This article discusses the rapid uptake and commercial success of GLP-1 receptor agonists for obesity management, highlighting their clinica
bmj.com·7d ago
Research Reveals Persistent Drug Pricing Distortions from PBM-Owned Pharmaceutical Companies
The article examines the persistent distortions in U.S. drug pricing, particularly focusing on vertically integrated pharmacy benefit manage
46brooklyn.com·7mo ago
Senators Investigate Pharmaceutical Companies' Direct-to-Consumer Telehealth Platforms for Steering Patients to High-Cost Drugs
U.S. senators are investigating direct-to-consumer (DTC) telehealth platforms operated by pharmaceutical companies like Eli Lilly and Pfizer
arstechnica.com·4mo ago
Drugmakers Plan Price Increases on 350+ Medications Despite Government Pressure
Drugmakers plan to raise U.S. prices on at least 350 branded medications in 2026, including COVID, RSV, and shingles vaccines, as well as ca
reuters.com·5mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.